EMEA, FDA jointly qualify renal biomarkers

[Source: EMEA] – The European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) have concluded their first joint qualification process for biomarkers.

Based on pooled data submitted by the Critical Path Institute